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Reply
In their Letter to the Editor, Takagi et al describe a pooled
analysis of three large randomized trials of endovascular aneurysm
repair (EVAR), wherein the survival curves of open surgical repair
and EVAR crossed at approximately 2.7 years of follow-up. In our
large cohort study of Medicare patients, we found that the survival
curves crossed as well. However, this event occurred about a year
earlier, at approximately 1.6 years.
Why might it be that patients who underwent endovascular
repair experienced a more durable survival advantage in the Takagi
pooled analysis of randomized trials as compared to our cohort
study of realworld Medicare patients? We believe this represents an
example of efficacy versus effectiveness.1
In the randomized trials, carefully selected patients underwent
Fig. Pooled survival curves of endovascular (EVAR) ansurgery in closely monitored centers of excellence, with specific dudits of processes, outcomes, medical adjuncts, and strict charac-
erization of pre- and postoperative risk. These trials clearly dem-
nstrated the efficacy of EVAR in reducing perioperative morbid-
ty and mortality.
Effectiveness, however, is established when a treatment works
ell in broad, generalizable settings.Our study—anational analysis of
eal-world outcomes inMedicare patients—demonstrates that EVAR
s effective in reducing perioperative mortality, even when the closely
onitored care present in randomized trials is not in place.
It would seem, therefore, that the difference in the care
rovided—between a randomized trial and the real world—plays
ome role in attenuating the survival advantage incurred by EVAR
n the treatment of abdominal aortic anuerysms. This difference
ay be attributable to patient, surgeon, or hospital factors, across
epair type as well as study type. Some of these factors may be
vident in comparison of patient, surgeon, and hospital character-
stics, and could theoretically be accounted for using risk adjust-
ent. However, even if we could compare all measurable charac-
eristics, adjusting for treatment bias in cohort studies is difficult, as
everal potential confounders are often unmeasurable, and even
dvanced statistical methods cannot always provide adequate risk
djustment.2,3 In closing, we appreciate Dr Takagi’s interest and
elieve their work reflects the important differences present be-
ween clinical trials and real-world implementation of new treat-
ents for abdominal aortic anuerysms.
hilip P. Goodney, MD, MS
ection of Vascular Surgery
artmouth-Hitchcock Medical Center
he Dartmouth Institute for Health Policy and Clinical Practice
ebanon, NH
EFERENCES
. Gould DA, Birkmeyer JD. Efficacy versus effectiveness of carotid endar-
terectomy. Eff Clin Pract 1999;2:30-6.
. Newhouse JP, McClellan M. Econometrics in outcomes research—the
use of instrumental variables. Annual Reviews in Public Health 1998;19:
17-34.
. Stukel TA. Analysis of observational studies in the presence of treatment
selection bias: effects of invasive cardiac management on AMI survival
using propensity score and instrumental variable methods. [see com-
ment]. JAMA 2007;297:278-85.
n surgical repair (OSR) of abdominal aortic aneurysm.oi:10.1016/j.jvs.2010.09.005
